A new era for genetic interpretation
ClinGen harnesses data, expert curation to improve patient care
2015-05-27
(Press-News.org) Millions of genetic variants have been discovered over the last 25 years, but interpreting the clinical impact of the differences in a person's genome remains a major bottleneck in genomic medicine. In a paper published in The New England Journal of Medicine on May 27, a consortium including investigators from Brigham and Women's Hospital (BWH) and Partners HealthCare present ClinGen, a program to evaluate the clinical relevance of genetic variants for use in precision medicine and research.
"We're dealing with massive amounts of information: more than 80 million genetic variants have been discovered to date, and for most of them, we have no clear understanding of their role in human health and disease," said Heidi Rehm, PhD, associate professor of Pathology at BWH and director of the Laboratory for Molecular Medicine at Partners HealthCare Personalized Medicine. "As genetic sequencing becomes more common, interpreting data in a meaningful way and standardizing practices is imperative. The enormity of the situation is daunting, but the potential impact on patient care has immense implications."
Clinicians and researchers hope to use information about genetic variants not only to make predictions about an individual's risk of disease but also to develop more accurate clinical trials and better, tailored treatments and care for patients.
However, labs and clinicians may interpret the same variant differently. ClinGen's mission is to resolve these differences. Members of ClinGen are actively working with laboratories around the world to help them share their data and implement standards developed by the American College of Medical Genetics and Genomics for interpreting genetic variants, with the goal of resolving interpretation differences.
An integral part of ClinGen is ClinVar: a database that contains more than 170,000 variant submissions from laboratories around the world. ClinGen has formed expert working groups to interpret the strength of gene-disease relationships, resolve differences in the interpretation of variants' clinical significance found in ClinVar, and move variants into the category of "expert panel reviewed" so they can be used more confidently in clinical decision-making.
"Our model works a little like Wikipedia: anyone can submit variants and interpretations to the database to rapidly enable shared resources, but that content is later curated by an expert group to standardize quality," said Rehm.
The ClinVar database is publicly accessible, meaning that clinicians and researchers as well as patients can look up information to find out what is known about a specific genetic variant, and the site gets an average of 5,000 hits per day.
ClinGen has also set up a patient portal where those who are interested in sharing their genetic data and health information can register. Known as GenomeConnect, the portal connects researchers, clinicians and patients to learn about the effects of genetics on human health and disease. Patients who have had or are considering having genetic testing can share their results and take surveys to share information about their health. De-identified information will be transferred to ClinVar and other ClinGen resources for advancing genomic knowledge and participants will receive updates when there are opportunities to connect with other participants who share the same condition, gene or genetic variant. Patients can access GenomeConnect to join, and ClinVar to search for genetic variants.
INFORMATION:
ClinGen is funded by the National Human Genome Research Institute, with additional funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Cancer Institute (U41 HG006834, U01 HG007436, U01 HG007437, HHSN261200800001E). ClinVar is supported by the Intramural Research Program of the NIH, National Library of Medicine.
ELSE PRESS RELEASES FROM THIS DATE:
2015-05-27
Tremendous advances have been made in decoding the human genome in recent years but critical questions remain regarding what these variants mean and how they can be applied in clinical practice. In a comprehensive paper to be published in The New England Journal of Medicine on May 27, 2015, "ClinGen: The Clinical Genome Resource," a consortium including investigators from the American College of Medical Genetics and Genomics (ACMG) provide a detailed overview of ClinGen, an NIH-supported program to evaluate the clinical relevance of genetic variants for use in precision ...
2015-05-27
Women who eat a Mediterranean diet could cut their risk of womb cancer by more than half (57 per cent), according to a study published today (Wednesday) in the British Journal of Cancer*.
The Italian researchers looked at the diets of over 5,000 Italian women to see how closely they stuck to a Mediterranean diet and whether they went on to develop womb cancer**.
The team broke the Mediterranean diet down into nine different components and measured how closely women stuck to them. The diet includes eating lots of vegetables, fruits and nuts, pulses, cereals and potatoes, ...
2015-05-27
If greenhouse-gas emissions continue to rise, glaciers in the Everest region of the Himalayas could experience dramatic change in the decades to come. A team of researchers in Nepal, France and the Netherlands have found Everest glaciers could be very sensitive to future warming, and that sustained ice loss through the 21st century is likely. The research is published today (27 May) in The Cryosphere, an open access journal of the European Geosciences Union (EGU).
"The signal of future glacier change in the region is clear: continued and possibly accelerated mass loss ...
2015-05-27
The psychological strain of being told that you may have breast cancer may be severe, even if it turns out later to be a false alarm. This is the finding of new research from the University of Copenhagen, which has just been published in the scientific journal Annals of Family Medicine. Researchers call for improving screening accuracy, thus reducing the number of false-positive mammograms.
It was a false alarm. You don't have breast cancer. This ought to be a happy message for women who have been through a mammography screening which initially showed signs of something ...
2015-05-27
OAK BROOK, Ill. - Degeneration of the white matter of the brain may be an early marker of specific types of Alzheimer's disease (AD), including early-onset AD, according to results of a new study published in the journal Radiology.
"Alzheimer's is a gray matter disease," said Federica Agosta, M.D., Ph.D., co-author of the study conducted at the Neuroimaging Research Unit, San Raffaele Scientific Institute in Milan, Italy. "However, white matter damage has a central role in how the disease strikes and progresses."
AD is an irreversible, progressive brain disease that ...
2015-05-27
The first practical guide to ensure the safe use of flavourings in e-cigarettes has been published (Regulatory Toxicology and Pharmacology DOI: 10.1016/j.yrtph.2015.05.018).
E-cigarettes and other vaping products contain a nicotine-based liquid that is vapourised and inhaled. There is no combustion so the user inhales vapour, not smoke. This means that e-cigarettes deliver nicotine without smoke toxicants. However, some in the public health community still have expressed concerns over the potential health impacts of flavourings used in e-cigarettes.
This is why the ...
2015-05-27
The spinal tumor grew back. Even though the 16-year old patient endured surgery a year earlier to remove and diagnose the lesion, it was back and its cause unknown. Determined to identify the tumor tissue and set the patient on an appropriate treatment regimen, Albert Telfeian, M.D., a neurosurgeon at Rhode Island Hospital and Hasbro Children's Hospital, performed the first reported case of extracting the tumor endoscopically while the patient was awake and under a local anesthetic. The minimally invasive procedure enabled accurate diagnosis, which evaded multiple physicians ...
2015-05-27
New research published today in Diabetologia (the journal of the European Association for the Study of Diabetes) indicates that consuming greater quantities of dietary fibre reduces the risk of developing type 2 diabetes.
Over 360 million people worldwide are estimated to be affected by diabetes, and this number is projected to increase to more than 550 million by 2030, with serious consequences for the health and economy of both developed and developing countries. While previous research has found an association between increased dietary fibre intake and a reduced risk ...
2015-05-27
Professor Teppo Järvinen and colleagues say drug treatment "can achieve at best a marginal reduction in hip fractures at the cost of unnecessary harms and considerable waste of monetary resources." The article is part of The BMJ's Too Much Medicine campaign -- to highlight the threat to human health and the waste of resources caused by unnecessary care.
Worldwide, about 1.5 million hip fractures occur each year. They impose an enormous burden on healthcare resources and, with a growing elderly population, their incidence is predicted to rise.
Before the late ...
2015-05-27
The results show that pills containing one of the newer types of progestogen hormone (drospirenone, desogestrel, gestodene, and cyproterone) are associated with an increased risk of VTE than pills containing older progestogens (levonorgestrel and norethisterone).
The researchers, based at the University of Nottingham, say this is "an important clarifying study" that "has sufficient power to provide reliable comparative findings for different formulations of combined oral contraceptives."
About 9% of women of reproductive age worldwide use oral contraceptives, rising ...
LAST 30 PRESS RELEASES:
[Press-News.org] A new era for genetic interpretation
ClinGen harnesses data, expert curation to improve patient care
